The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel–Lindau Disease: A Retrospective Study of 32 Patients

Background: Von Hippel-Lindau (VHL) disease is an autosomal-dominant hereditary cancer syndrome. Currently, studies on tyrosine kinase inhibitor (TKI) therapy for VHL disease are scarce. In this study, we retrospectively evaluated the efficacy and safety of four TKIs in patients with VHL disease. Me...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Ma, Kaifang, Hong, Baoan, Zhou, Jingcheng, Gong, Yanqing, Wang, Jiangyi, Liu, Shengjie, Peng, Xiang, Zhou, Bowen, Zhang, Jiufeng, Xie, Haibiao, Zhang, Kenan, Li, Lei, Cai, Desheng, Wang, Zixin, Cai, Lin, Gong, Kan
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6839035/
https://ncbi.nlm.nih.gov/pubmed/31737565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01122
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars